Department of Surgery, National Taiwan University Hospital, No. 7, Chung-Shan South Road, Taipei 100, Taiwan.
Surg Today. 2012 Oct;42(10):1014-8. doi: 10.1007/s00595-012-0176-y. Epub 2012 Apr 7.
Hereditary protein S deficiency is a risk factor which may predispose patients to venous thrombosis. Deep venous thrombosis of the lower extremities can result in painful congestion, while the presence of mesenteric venous thrombosis (MVT) can cause abdominal emergencies. We herein report a protein S-deficient patient presenting with acute portomesenteric venous thrombosis. Early management using anticoagulant therapy was initially successful. However, the subsequent bowel stricture resulting from the ischemic insult was further managed with a surgical bypass. The patient was kept on long-term thrombophylaxis. The treatment strategy for MVT with bowel ischemia has evolved from aggressive portomesenteric thrombectomy with resection of the involved bowel, to conservative anticoagulation to recanalize thrombotic mesenteric veins with bowel preservation. Surgical intervention is reserved for transmural necrosis or bowel perforation. The perioperative thrombophylaxis of inherited thrombophilic patients is also important for preventing further thromboembolic events.
遗传性蛋白 S 缺乏症是一种可能使患者易患静脉血栓形成的风险因素。下肢深静脉血栓形成可导致疼痛性充血,而肠系膜静脉血栓形成(MVT)则可导致腹部急症。本文报告了一例蛋白 S 缺乏症患者,其表现为急性门腔静脉血栓形成。早期使用抗凝治疗的管理最初是成功的。然而,由于缺血损伤导致的随后的肠狭窄进一步通过手术旁路进行了治疗。患者长期接受血栓预防治疗。MVT 伴肠缺血的治疗策略已从积极的门腔静脉血栓切除术联合受累肠段切除术演变为保守抗凝治疗以再通血栓性肠系膜静脉并保留肠段。手术干预保留用于穿透性坏死或肠穿孔。对于遗传性血栓形成倾向患者,围手术期的血栓预防治疗对于预防进一步的血栓栓塞事件也很重要。